Gilead to create 140 new jobs in Dublin in €7m investment

Gilead hiring to occur over next 18 months with roles expected to be filled by early 2022.

Up to 140 new jobs are to be created in Dublin by Gilead Sciences as part of a €7m investment in the company’s Irish operations.

As part of this expansion, the company will also establish a paediatric centre of excellence in Ireland.

“It demonstrates a huge vote of confidence in Ireland and our strong value proposition”

Gilead’s manufacturing operations in Ireland supply countries across Europe and other parts of the world outside of the United States. The company has commenced the recruitment process and expects the positions to be filled by early 2022. Gilead is adding positions at all levels in departments including clinical development, process development and analytical operations, legal, human resources, supply chain, information technology, facilities and engineering, and financial shared services.

“This is really positive news from the pharmaceutical industry in Ireland,” said IDA Ireland CEO Martin Shanahan.

“We are delighted that, off the back of an already successful operation in the country, Gilead has decided to invest further in Ireland, creating 140 new roles.

“It demonstrates a huge vote of confidence in Ireland and our strong value proposition. I wish Gilead continued success with their Irish operations and assure them of IDA Ireland’s continued support.”

20 successful years in Ireland

This announcement builds upon Gilead’s 20 years of successful operations in Ireland.

Gilead has invested more than €225m in Ireland and has continually expanded its presence in the country. Currently, the company has 370 full-time employees in Ireland and an additional 119 contingent workers.

“Gilead has a long record of operating in Ireland and our teams here have played a critical role in ensuring that patients in Europe and other parts of the world outside of the United States have access to our medicines,” explained David Cadogan, vice-president, Manufacturing Operations and General Manager, Gilead Sciences Ireland.

“With this additional investment, we are looking forward to continuing this important work and growing our presence here in Ireland.”

Gilead’s sites in Ireland include a drug product manufacturing and packing facility in Carrigtwohill Co. Cork that manufactures and packages 22 Gilead drug products. The facility manufactures HIV and HCV solid oral products, representing 25 percent of Gilead’s total solid oral drug production.

The company also has a financial shared services centre in Little Island, Co. Cork, which supports Gilead affiliates in Europe, Middle East, Asia and South America and was established 11 years ago, and a distribution centre in Dublin that distributes to 90 markets worldwide.

Tánaiste and Minister for Enterprise, Trade & Employment, Leo Varadkar TD said: “Gilead has been steadily growing its presence here over the last 20 years and today’s announcement underlines the company’s commitment to Ireland.

“This expansion shows that Ireland offers the right conditions – particularly our skilled and talented workforce – to allow companies like Gilead to grow their operations here. I wish them well in this next exciting chapter.”

Written by John Kennedy (john.kennedy3@boi.com)

Published: 8 July, 2020